Skip to main content

NOVO NORDISK A S

For the period ended Dec 31, 2023. Filed Jan 31, 2024.

View on SEC.gov

About this filing

The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.

FY2023 · Filed Jan 31, 2024

NVO$40.31+0.0%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Cover page

Show cover page

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 20-F

(Mark One)

oREGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
OR
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
OR
oSHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number:333-82318

NOVO NORDISK A/S

(Exact name of Registrant as specified in its charter)

Not applicableThe Kingdom of Denmark
(Translation of Registrant’s name into English)(Jurisdiction of incorporation or organization)

Novo Alle 1

DK-2880 Bagsværd

Denmark

(Address of principal executive offices)

Karsten Munk Knudsen

Executive vice president and chief financial officer

Tel: +45 4444 8888

E-mail: kmkn@novonordisk.com

Novo Alle 1, DK-2880 Bagsværd, Denmark

(Name, Telephone, E-mail and Address of Company Contact Person)

Securities registered or to be registered pursuant to Section 12(b) of the Act:
Title of each class:Trading Symbol(s):Name of each exchange on which registered:
B shares, nominal value DKK 0.10 eachNew York Stock Exchange*
American Depositary Receipts, each representing one B ShareNVONew York Stock Exchange
* Not for trading, but only in connection with the registration of American Depositary Receipts, pursuant to the requirements of the Securities and Exchange Commission.

Securities registered or to be registered pursuant to Section 12(g) of the Act: None

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None

Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the Annual Report:

A shares, nominal value DKK 0.10 each:1,074,872,000
B shares, nominal value DKK 0.10 each:3,435,128,000

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Yeso No x

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of “large accelerated filer”, “accelerated filer”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer x Accelerated filero Non-accelerated filero Emerging growth companyo

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. x

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. o

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). o

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filling:

U.S. GAAP o International Financial Reporting Standards as issued by the International Accounting Standards Board x Other o

If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow:

Item 17 o Item 18 o

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yeso No x

TABLE OF CONTENTS

INTRODUCTION2
Part I
ITEM 1IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS3
ITEM 2OFFER STATISTICS AND EXPECTED TIMETABLE3
ITEM 3KEY INFORMATION3
ITEM 4INFORMATION ON THE COMPANY4
ITEM 4AUNRESOLVED STAFF COMMENTS10
ITEM 5OPERATING AND FINANCIAL REVIEW AND PROSPECTS10
ITEM 6DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES14
ITEM 7MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS18
ITEM 8FINANCIAL INFORMATION19
ITEM 9THE OFFER AND LISTING19
ITEM 10ADDITIONAL INFORMATION20
ITEM 11QUALITATIVE AND QUANTITATIVE DISCLOSURES ABOUT MARKET RISK23
ITEM 12DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES23
Part II
ITEM 13DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES25
ITEM 14MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS25
ITEM 15CONTROLS AND PROCEDURES25
ITEM 16AAUDIT COMMITTEE FINANCIAL EXPERT26
ITEM 16BCODE OF ETHICS26
ITEM 16CPRINCIPAL ACCOUNTANT FEES AND SERVICES26
ITEM 16DEXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES27
ITEM 16EPURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS27
ITEM 16FCHANGE IN REGISTRANT'S CERTIFYING ACCOUNTANT28
ITEM 16GCORPORATE GOVERNANCE28
ITEM 16HMINE SAFETY DISCLOSURE30
ITEM 16IDISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS30
ITEM 16IINSIDER TRADING POLICIES30
ITEM 16KCYBERSECURITY30
Part III
ITEM 17FINANCIAL STATEMENTS32
ITEM 18FINANCIAL STATEMENTS32
ITEM 19EXHIBITS35
SIGNATURESSIGNATURES37

Novo Nordisk Form 20-F 2023

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.